The role of microRNAs in axon regeneration after peripheral nerve injury: a bibliometric analysis

Front Neurol. 2024 Mar 6:15:1348048. doi: 10.3389/fneur.2024.1348048. eCollection 2024.

Abstract

Objective: This study analyzed the current research hotspots and future development trends of the therapeutic effects of microRNA on PNI axonal regeneration through bibliometric methods. Moreover, the current advantages and disadvantages of this field as well as future development prospects are discussed in depth.

Methods: CiteSpace V and VOSviewer were used as bibliometric tools to complete the analysis of the research focus and direction of the published articles. To supplement, sort out, and summarize, we analyzed the research status of the study on the application of microRNAs for axonal regeneration after peripheral nerve injury from 2013 to 2023.

Results: A total of 207 publications were retrieved from the Web of Science database. After exclusion and screening, a final selection of 174 articles that met the research criteria. These 174 articles were authored by a total of 846 individuals, representing 24 countries and 199 institutions. Additionally, this study presents information on the annual publication output, country distribution, top 5 contributing authors, top 5 most cited articles, and top 10 contributing institutions.

Conclusion: As one of the hottest topics today, microRNAs have become the current research hotspot in neural inflammation, neural cell repair and regeneration, neural protection, and functional recovery. With more investment in research in this field, more high-quality articles will be published in both domestic and international outstanding journals, which will bring a new era for the treatment of peripheral nerve injury.

Keywords: axonal regeneration; bibliomeric analysis; microRNAs; peripheral nerve injury; visualization.

Publication types

  • Systematic Review

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The research is supported by the Open Research Program of the Key State Laboratory of Pathogenesis, Prevention, and Treatment of High Incidence Diseases in Central Asia (No: SKL-HIDCA-2022-16), National Natural Scientific Foundation of China (Nos: 82260252, 82374487, 82074452, and 81860235), “Tian Chi Ying Cai” Young Doctors’ Talent Introduction Program of Xinjiang Uyghur Autonomous Region, Natural Scientific Foundation of Xinjiang Uyghur Autonomous Region (Nos: 2022D01C330, 2022D01C331, 2022D01C583, and 2022D01C586), and the Open Research Program of the Key Laboratory of High Incidence Disease Research in Xingjiang (Xinjiang Medical University) Ministry of Education (No: 2023A03).